Condition: Cardiopulmonary Arrest · Sponsor: Seoul National University Hospital
The investigators propose a multicenter randomized controlled trial in South Korea and Taiwan to observe the clinical effects of REBOA on nontraumatic out-of-hospital-cardiac-arrest (OHCA) patients. While REBOA has been traditionally used in trauma for hemorrhage control, it has also shown promising results in nontraumatic cardiac arrests by rerouting circulation to increase perfusion in the coronary and brain.
This description comes directly from the study's public registry record.
Hee Eun Kim · 82-31-787-7579 · hekim9111@gmail.com
Dong Hyun Jang · 82-31-787-7819 · jang0621@gmail.com
Always discuss trial participation with your own doctor first.
| Seoul National Univeristy Bundang Hospital | Seongnam-si, Gyeonggi-do, South Korea | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06031623